The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.
Tae HJ, Kim JM, Park S, Tomiya N, Li G, Wei W, Petrashevskaya N, Ahmet I, Pang J, Cruschwitz S, Riebe RA, Zhang Y, Morrell CH, Browe D, Lee YC, Xiao RP, Talan MI, Lakatta EG, Lin L.
Tae HJ, et al. Among authors: tomiya n.
J Mol Med (Berl). 2013 Dec;91(12):1369-81. doi: 10.1007/s00109-013-1091-4. Epub 2013 Oct 17.
J Mol Med (Berl). 2013.
PMID: 24132651
Free PMC article.